A feasibility study of using gold seeds as fiducial markers for bladder localization during radical radiotheraphy

British Journal of Radiology

Volumn 80, Issue 952, 2007, Pages 279-283

  Mangar, S ^a   Thompson, A ^a   Miles, E ^a   Huddart, R ^a   Horwich, A ^a   Khoo, Vincent ^a,b  

^a ROYAL MARSDEN HOSPITAL   (United Kingdom)

^b INSTITUTE OF CANCER RESEARCH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GOLD;

ARTICLE; BLADDER CANCER; CANCER LOCALIZATION; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; CYSTECTOMY; CYSTOSCOPE; DIAGNOSTIC IMAGING; DIATHERMY; DISEASE MARKER; FEASIBILITY STUDY; HUMAN; PATIENT ASSESSMENT; PATIENT CARE PLANNING; RADIATION APPLICATOR;

CYSTOSCOPY; FEASIBILITY STUDIES; GOLD; HUMANS; PROSTHESES AND IMPLANTS; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RADIOTHERAPY, CONFORMAL; TOMOGRAPHY, X-RAY COMPUTED; URINARY BLADDER NEOPLASMS;

EID: 34347404507     PISSN: 00071285     EISSN: None     Source Type: Journal    
DOI: 10.1259/bjr/54321311     Document Type: Article

References (15)

1. Turner SL, Swindell R, Bowl N, Marrs J, et al. Bladder movement during radiation therapy for bladder cancer: implications for treatment planning. Int J Radiat Oncol Biol Phys 1997;39:355-60.
2. Roeske JC, Forman JD, Mesna CF, He T, et al. Evaluation of changes in the size and location of prostate, seminal vesicles, bladder and rectum during a course of external beam radiotherapy. Int J Radiat Oncol Biol Phys 1995; 33:1321-9.
3. van Herk M, Bruce A, Kroes APG, et al. Quantification of organ motion during conformal radiotherapy of the prostate by three-dimensional image registration. Int J Radiat Oncol Biol Phys 1995;33:1311-20.
4. Sur RK, Clinkard J, Jones WG, Taylor RE, et al. Changes in target volume during radiotherapy treatment for invasive bladder carcinoma. Clin Oncol 1993;5:30-3.
5. Muren LP, Smaaland R, Dahl O. Conformal radiotherapy of urinary bladder cancer. Radiother Oncol 2004;73:387-98.
6. McBain CA, Logue JP. Radiation therapy for muscle-invasive bladder cancer: treatment planning and delivery in the 21st century. Semin Radiat Oncol 2005;15:42-8.
7. Dehnad H, Nederveen AJ, van der Heide UA, et al. Clinical feasibility study for the use of implanted gold seeds in the prostate as reliable positioning markers during megavoltage irradiation. Radiat Oncol 2003;67:295-302.
8. Crook JM, Raymond Y, Salhani D, Yang H, Esche B. Prostate motion during standard radiotherapy as assessed by fiducial markers. Radiother Oncol 1995;37:35-42.
9. Langen KM, Pouliot J, Anezinos RTT, Aubin M, et al. Evaluation of ultrasound-based prostate localization for image-guided radiotherapy. Int J Radiat Oncol Biol Phys 2003;57:635-44.
10. van der Steen-Banasik EM, Visser AG, Reinders JG, Heijbroek RP, et al. Saving bladders with brachytherapy: implantation technique and results. Int J Radiat Oncol Biol Phys 2002;53:622-9.
11. Pos F, Horenblas S, Dom P, Mooren L, Bartelink H. Organ preservation in invasive badder cancer: brachytherapy, an alternative to cystectomy and combined modality treatment? Int J Radiat Oncol Biol Phys 2005;61:618-86.
12. Henry AM, Stratford J, Davies J, McCarthy C, et al. An assessment of clinically optimal gold marker length and diameter for pelvic radiotherapy verification using an amorphous silicon flat panel electronic portal imaging device. Br J Radiol 2005;78:737-41.
13. Muren LP, Smaaland R, Dahl O. Organ motion, set-up variation and treatment margins in radical radiotherapy of urinary bladder cancer. Radiother Oncol 2003;69:291-304.
14. Meijer GJ, Rasch C, Remeijer P, Lebesque JV. Three-dimensional analysis of delineation errors, setup errors, and organ motion during radiotherapy of bladder cancer. Int J Radiat Oncol Biol Phys 2003;55:1277-87.
15. Fokdal L, Honore H, Hoyer M, Meldgaard P, Fode K, von der Maase H. Impact of changes in bladder and rectal filling volume on organ motion and dose distribution of the bladder in radiotherapy for urinary bladder cancer. Int J Radiat Oncol Biol Phys 2004;59:436-44.